SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-028463
Filing Date
2022-11-04
Accepted
2022-11-04 16:18:55
Documents
66
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bcrx-20220930.htm   iXBRL 10-Q 1688187
2 EX-10.1 exhibit101-biocrystxbcx993.htm EX-10.1 52515
3 EX-10.2 exhibit102-biocrystxamendm.htm EX-10.2 46733
4 EX-10.4 bcrx-20220930xexhibit104.htm EX-10.4 12465
5 EX-31.1 bcrx-20220930xexx311.htm EX-31.1 9576
6 EX-31.2 bcrx-20220930xexx312.htm EX-31.2 9550
7 EX-32.1 bcrx-20220930xexx321.htm EX-32.1 4725
8 EX-32.2 bcrx-20220930xexx322.htm EX-32.2 4655
  Complete submission text file 0001628280-22-028463.txt   7547783

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bcrx-20220930.xsd EX-101.SCH 62273
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bcrx-20220930_cal.xml EX-101.CAL 50195
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bcrx-20220930_def.xml EX-101.DEF 253001
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bcrx-20220930_lab.xml EX-101.LAB 658367
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bcrx-20220930_pre.xml EX-101.PRE 381002
60 EXTRACTED XBRL INSTANCE DOCUMENT bcrx-20220930_htm.xml XML 1224484
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 221362587
SIC: 2836 Biological Products, (No Diagnostic Substances)